Collection and Distribution of Biospecimens for Novel Research Uses
Launched by ISPECIMEN INC · Feb 19, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Collection and Distribution of Biospecimens for Novel Research Uses," is focused on gathering biological samples from patients to help researchers discover new ways to diagnose and treat various health conditions, including cancer, autoimmune diseases, and complications during high-risk pregnancies. The goal is to build a network of hospitals and labs that can provide these samples, which will be used for important medical research and education.
To participate, individuals aged 7 years and older may be eligible, as long as they meet specific requirements for the research and provide consent. Participants can expect a medical evaluation to ensure their health is suitable for the study, and they will need to sign consent forms for their samples to be used in research. It’s important to note that this study is currently recruiting participants, so if you or someone you know is interested in contributing to medical research, this could be an opportunity to help advance health care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individual is developmentally aged 7 years old and above for RUO collections (only)
- • Individual meets requirements of a current request for research materials from iSpecimen
- • If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and/or the review of an updated medical history as provided by the participant
- • Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf.
- • Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf
- Exclusion Criteria:
- • Subjects that do not meet the inclusion criteria outlined above.
About Ispecimen Inc
iSpecimen Inc. is a leading provider of biospecimens and related services, dedicated to advancing biomedical research and personalized medicine. By leveraging a robust network of clinical sites and biorepositories, iSpecimen facilitates the collection, processing, and distribution of high-quality human samples for use in various research applications, including drug development and diagnostics. Committed to enhancing the efficiency and effectiveness of clinical trials, iSpecimen employs innovative technology and a patient-centric approach to ensure compliance with regulatory standards while meeting the diverse needs of researchers and pharmaceutical companies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Huntsville, Alabama, United States
Lexington, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials